Connecticut 2023 Regular Session

Connecticut House Bill HB06913 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	LCO \\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-R01-
4		-	HB.docx
5		-	1 of 9
	3	+	LCO No. 6013 1 of 5
6	4
7		-	General Assembly ~~Substitute~~ Bill No. 6913
	5	+	General Assembly Raised Bill No. 6913
8	6		January Session, 2023
	7	+	LCO No. 6013
9	8
	9	+
	10	+	Referred to Committee on PUBLIC HEALTH
	11	+
	12	+
	13	+	Introduced by:
	14	+	(PH)
10	15
11	16
12	17
13	18
14	19		AN ACT CONCERNING OPIOIDS.
15	20		Be it enacted by the Senate and House of Representatives in General
16	21		Assembly convened:
17	22
18	23		Section 1. (NEW) (Effective from passage) A substance abuse treatment 1
19	24		facility licensed as an institution pursuant to section 19a-490 of the 2
20	25		general statutes shall (1) retain records regarding each person who 3
21		-	receives treatment from the facility, including, but not limited to, the 4
22		-	person's address, telephone number and any additional contact 5
23		-	information the person agrees to provide, for a period of time after the 6
24		-	person last receives treatment from the facility that is in accordance with 7
25		-	standard record-keeping practices for substance abuse treatment 8
26		-	facilities; (2) contact or attempt to contact the person for a status update 9
27		-	on the person's physical and mental health not less than once every four 10
28		-	months, for a period of not less than one year, after the person last 11
29		-	received treatment from such facility; and (3) offer to or refer such 12
30		-	person to additional substance use disorder treatment services if the 13
31		-	person expresses a need or desire for such services. 14
32		-	Sec. 2. Section 10a-55t of the general statutes is repealed and the 15
33		-	following is substituted in lieu thereof (Effective from passage): 16
34		-	(a) Not later than January 1, 2020, the president of each institution of 17
35		-	higher education in the state shall (1) develop and implement a policy 18 Substitute Bill No. 6913
	26	+	receives treatment from the facility for not less than one year after the 4
	27	+	person last receives treatment, including, but not limited to, the person's 5
	28	+	address, telephone number and any additional contact information the 6
	29	+	person agrees to provide; (2) contact or attempt to contact the person for 7
	30	+	a status update on the person's physical and mental health not less than 8
	31	+	once every four months, for a period of not less than one year, after the 9
	32	+	person last received treatment from such facility; and (3) offer to or refer 10
	33	+	such person to additional substance use disorder treatment services if 11
	34	+	the person expresses a need or desire for such services. 12
	35	+	Sec. 2. Section 10a-55t of the general statutes is repealed and the 13
	36	+	following is substituted in lieu thereof (Effective from passage): 14
	37	+	(a) Not later than January 1, 2020, the president of each institution of 15 Raised Bill No. 6913
36	38
37	39
38		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
39		-	R01-HB.docx }
40		-	2 of 9
41	40
42		-	consistent with subsection (b) of this section concerning the availability 19
43		-	and use of opioid antagonists, as defined in section 17a-714, by students 20
44		-	and employees of the institution, (2) submit such policy to the 21
45		-	Department of Consumer Protection for approval, and (3) upon 22
46		-	approval of the department, post such policy on the institution's Internet 23
47		-	web site. 24
48		-	(b) The policy of each institution of higher education concerning the 25
49		-	availability and use of opioid antagonists shall (1) designate a medical 26
50		-	professional or public safety professional to oversee the purchase, 27
51		-	storage and distribution of opioid antagonists on each of its campuses, 28
52		-	(2) identify the location or locations on each of its campuses where the 29
53		-	opioid antagonists are stored, which location or locations shall be made 30
54		-	known and accessible to students and employees of such institution, (3) 31
55		-	require maintenance of the supply of opioid antagonists in accordance 32
56		-	with the manufacturer's guidelines, and (4) require a representative of 33
57		-	the institution to call 911 or notify a local emergency medical services 34
58		-	provider prior to, during or as soon as practicable after each use of an 35
59		-	opioid antagonist on the institution's campus that is reported to the 36
60		-	institution or observed by a medical professional or public safety 37
61		-	professional, unless the person to whom the opioid antagonist was 38
62		-	administered has already received medical treatment for his or her 39
63		-	opioid-related drug overdose. 40
64		-	(c) Not later than January 1, 2024, the president of each institution of 41
65		-	higher education shall report, in accordance with the provisions of 42
66		-	section 11-4a, to the joint standing committees of the General Assembly 43
67		-	having cognizance of matters relating to public health and higher 44
68		-	education and employment advancement regarding the 45
69		-	implementation of the policy concerning the availability and use of 46
70		-	opioid antagonists on each campus. 47
71		-	Sec. 3. (NEW) (Effective from passage) (a) As used in this section: 48
72		-	(1) "Prescription digital therapeutic" means a software-based medical 49
73		-	device that (A) has been cleared or approved by the federal Food and 50 Substitute Bill No. 6913
	41	+	LCO No. 6013 2 of 5
	42	+
	43	+	higher education in the state shall (1) develop and implement a policy 16
	44	+	consistent with subsection (b) of this section concerning the availability 17
	45	+	and use of opioid antagonists, as defined in section 17a-714, by students 18
	46	+	and employees of the institution, (2) submit such policy to the 19
	47	+	Department of Consumer Protection for approval, and (3) upon 20
	48	+	approval of the department, post such policy on the institution's Internet 21
	49	+	web site. 22
	50	+	(b) The policy of each institution of higher education concerning the 23
	51	+	availability and use of opioid antagonists shall (1) designate a medical 24
	52	+	professional or public safety professional to oversee the purchase, 25
	53	+	storage and distribution of opioid antagonists on each of its campuses, 26
	54	+	(2) identify the location or locations on each of its campuses where the 27
	55	+	opioid antagonists are stored, which location or locations shall be made 28
	56	+	known and accessible to students and employees of such institution, (3) 29
	57	+	require maintenance of the supply of opioid antagonists in accordance 30
	58	+	with the manufacturer's guidelines, and (4) require a representative of 31
	59	+	the institution to call 911 or notify a local emergency medical services 32
	60	+	provider prior to, during or as soon as practicable after each use of an 33
	61	+	opioid antagonist on the institution's campus that is reported to the 34
	62	+	institution or observed by a medical professional or public safety 35
	63	+	professional, unless the person to whom the opioid antagonist was 36
	64	+	administered has already received medical treatment for his or her 37
	65	+	opioid-related drug overdose. 38
	66	+	(c) Not later than January 1, 2024, the president of each institution of 39
	67	+	higher education shall report, in accordance with the provisions of 40
	68	+	section 11-4a, to the joint standing committees of the General Assembly 41
	69	+	having cognizance of matters relating to public health and higher 42
	70	+	education and employment advancement regarding the 43
	71	+	implementation of the policy concerning the availability and use of 44
	72	+	opioid antagonists on each campus. 45
	73	+	Sec. 3. (NEW) (Effective from passage) (a) As used in this section: 46
	74	+	(1) "Prescription digital therapeutic" means a software-based medical 47 Raised Bill No. 6913
74	75
75	76
76		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
77		-	R01-HB.docx }
78		-	3 of 9
79	77
80		-	Drug Administration, (B) is intended to prevent, manage or treat a 51
81		-	substance use disorder, (C) a licensed health care provider prescribes for 52
82		-	a patient, and (D) a patient may access through an application on a 53
83		-	mobile device; 54
84		-	(2) "Licensed health care provider" means a licensed health care 55
85		-	provider with experience treating patients with a substance use disorder 56
86		-	who is authorized to prescribe a prescription digital therapeutic within 57
87		-	the scope of such provider's practice; 58
88		-	(3) "Opioid use disorder" means a medical condition characterized by 59
89		-	a problematic pattern of opioid use and misuse leading to clinically 60
90		-	significant impairment or distress; and 61
91		-	(4) "Substance use disorder" means a pattern of use of alcohol or other 62
92		-	substances that meets the applicable diagnostic criteria delineated in the 63
93		-	most recent edition of the American Psychiatric Association's 64
94		-	Diagnostic and Statistical Manual of Mental Disorders. 65
95		-	(b) Not later than January 1, 2024, the Department of Mental Health 66
96		-	and Addiction Services, in collaboration with the Department of Public 67
97		-	Health, shall establish a pilot program pursuant to which licensed 68
98		-	health care providers may prescribe prescription digital therapeutics to 69
99		-	patients with opioid use disorder or another substance use disorder for 70
100		-	the management or treatment of such disorder. The Commissioners of 71
101		-	Mental Health and Addiction Services and Public Health shall jointly 72
102		-	develop eligibility criteria and guidelines for the pilot program. Such 73
103		-	guidelines shall include, but need not be limited to, authorizing the 74
104		-	provision of a prescription digital therapeutic for not less than a three-75
105		-	month period for up to one thousand such patients. 76
106		-	(c) Not later than January 1, 2025, the Commissioner of Mental Health 77
107		-	and Addiction Services shall report, in accordance with the provisions 78
108		-	of section 11-4a of the general statutes, to the joint standing committee 79
109		-	of the General Assembly having cognizance of matters relating to public 80
110		-	health on the implementation of the pilot program and any 81 Substitute Bill No. 6913
	78	+	LCO No. 6013 3 of 5
	79	+
	80	+	device that (A) has been cleared or approved by the federal Food and 48
	81	+	Drug Administration, (B) is intended to prevent, manage or treat a 49
	82	+	substance use disorder, (C) a licensed health care provider prescribes for 50
	83	+	a patient, and (D) a patient may access through an application on a 51
	84	+	mobile device; 52
	85	+	(2) "Licensed health care provider" means a licensed health care 53
	86	+	provider with experience treating patients with a substance use disorder 54
	87	+	who is authorized to prescribe a prescription digital therapeutic within 55
	88	+	the scope of such provider's practice; 56
	89	+	(3) "Opioid use disorder" means a medical condition characterized by 57
	90	+	a problematic pattern of opioid use and misuse leading to clinically 58
	91	+	significant impairment or distress; and 59
	92	+	(4) "Substance use disorder" means a pattern of use of alcohol or other 60
	93	+	substances that meets the applicable diagnostic criteria delineated in the 61
	94	+	most recent edition of the American Psychiatric Association's 62
	95	+	Diagnostic and Statistical Manual of Mental Disorders. 63
	96	+	(b) Not later than January 1, 2024, the Department of Mental Health 64
	97	+	and Addiction Services, in collaboration with the Department of Public 65
	98	+	Health, shall establish a pilot program pursuant to which licensed 66
	99	+	health care providers may prescribe prescription digital therapeutics to 67
	100	+	patients with opioid use disorder or another substance use disorder for 68
	101	+	the management or treatment of such disorder. The Commissioners of 69
	102	+	Mental Health and Addiction Services and Public Health shall jointly 70
	103	+	develop eligibility criteria and guidelines for the pilot program. Such 71
	104	+	guidelines shall include, but need not be limited to, authorizing the 72
	105	+	provision of a prescription digital therapeutic for not less than a three-73
	106	+	month period for up to one thousand such patients. 74
	107	+	(c) Not later than January 1, 2025, the Commissioner of Mental Health 75
	108	+	and Addiction Services shall report, in accordance with the provisions 76
	109	+	of section 11-4a of the general statutes, to the joint standing committee 77
	110	+	of the General Assembly having cognizance of matters relating to public 78
	111	+	health on the implementation of the pilot program and any 79 Raised Bill No. 6913
111	112
112	113
113		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
114		-	R01-HB.docx }
115		-	4 of 9
116	114
117		-	recommendations for continuing or expanding the pilot program. 82
118		-	Sec. 4. Section 21a-317 of the general statutes is repealed and the 83
119		-	following is substituted in lieu thereof (Effective October 1, 2023): 84
120		-	Every practitioner who distributes, administers or dispenses any 85
121		-	controlled substance or who proposes to engage in distributing, 86
122		-	prescribing, administering or dispensing any controlled substance 87
123		-	within this state shall (1) obtain a certificate of registration issued by the 88
124		-	Commissioner of Consumer Protection in accordance with the 89
125		-	provisions of this chapter, (2) if the practitioner is engaged in 90
126		-	prescribing a controlled substance, register for access to the electronic 91
127		-	prescription drug monitoring program established pursuant to 92
128		-	subsection (j) of section 21a-254 in a manner prescribed by the 93
129		-	commissioner, and (3) if the practitioner is engaged in transporting a 94
130		-	controlled substance for the purpose of treating a patient in a location 95
131		-	that is different than the address that the practitioner provided to the 96
132		-	Department of Consumer Protection as a registrant, as defined in section 97
133		-	21a-240, notify the department, in a manner prescribed by the 98
134		-	commissioner, of the intent to transport such controlled substance and, 99
135		-	after dispensing such controlled substance, return any remaining 100
136		-	amount of such controlled substance to a secure location at the address 101
137		-	provided to the department. If the practitioner cannot return any 102
138		-	remaining amount of such controlled substance to such address, the 103
139		-	commissioner may approve an alternate location, provided such 104
140		-	location is also approved by the federal Drug Enforcement Agency, or 105
141		-	any successor agency. The practitioner shall report any dispensation by 106
142		-	the practitioner of a controlled substance that occurs at a location other 107
143		-	than the address provided to the department to the prescription drug 108
144		-	monitoring program pursuant to subsection (j) of section 21a-254 upon 109
145		-	returning to such address. No practitioner shall transport a controlled 110
146		-	substance under subdivision (3) of this section to a location that is within 111
147		-	five hundred feet of an elementary or secondary school ground, child 112
148		-	care center, playground or public park, except a location that is a private 113
149		-	residence where the dispensation of the controlled substance occurs 114 Substitute Bill No. 6913
	115	+	LCO No. 6013 4 of 5
	116	+
	117	+	recommendations for continuing or expanding the pilot program. 80
	118	+	Sec. 4. Section 21a-317 of the general statutes is repealed and the 81
	119	+	following is substituted in lieu thereof (Effective October 1, 2023): 82
	120	+	Every practitioner who distributes, administers or dispenses any 83
	121	+	controlled substance or who proposes to engage in distributing, 84
	122	+	prescribing, administering or dispensing any controlled substance 85
	123	+	within this state shall (1) obtain a certificate of registration issued by the 86
	124	+	Commissioner of Consumer Protection in accordance with the 87
	125	+	provisions of this chapter, (2) if the practitioner is engaged in 88
	126	+	prescribing a controlled substance, register for access to the electronic 89
	127	+	prescription drug monitoring program established pursuant to 90
	128	+	subsection (j) of section 21a-254 in a manner prescribed by the 91
	129	+	commissioner, and (3) if the practitioner is engaged in transporting a 92
	130	+	controlled substance for the purpose of treating a patient in a location 93
	131	+	that is different than the address that the practitioner provided to the 94
	132	+	Department of Consumer Protection as a registrant, as defined in section 95
	133	+	21a-240, notify the department, in a manner prescribed by the 96
	134	+	commissioner, of the intent to transport such controlled substance and, 97
	135	+	after dispensing such controlled substance, return any remaining 98
	136	+	amount of such controlled substance to a secure location at the address 99
	137	+	provided to the department. If the practitioner cannot return any 100
	138	+	remaining amount of such controlled substance to such address, the 101
	139	+	commissioner may approve an alternate location, provided such 102
	140	+	location is also approved by the federal Drug Enforcement Agency, or 103
	141	+	any successor agency. The practitioner shall report any dispensation by 104
	142	+	the practitioner of a controlled substance that occurs at a location other 105
	143	+	than the address provided to the department to the prescription drug 106
	144	+	monitoring program pursuant to subsection (j) of section 21a-254 upon 107
	145	+	returning to such address. No practitioner shall transport a controlled 108
	146	+	substance under subdivision (3) of this section to a location that is within 109
	147	+	five hundred feet of an elementary or secondary school ground, child 110
	148	+	care center, playground or public park, except a location that is a private 111
	149	+	residence where the dispensation of the controlled substance occurs 112
	150	+	inside such residence. 113 Raised Bill No. 6913
150	151
151	152
152		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
153		-	R01-HB.docx }
154		-	5 of 9
155	153
156		-	inside such residence. 115
157		-	Sec. 5. (Effective from passage) (a) The Departments of Mental Health 116
158		-	and Addiction Services, Social Services and Children and Families shall, 117
159		-	in consultation with direct service providers and individuals with lived 118
160		-	experience, evaluate existing programs for persons with substance use 119
161		-	disorder who are caregivers of children and the barriers to treatment of 120
162		-	such persons and develop a plan for the establishment and 121
163		-	implementation of programs for the treatment of such persons and their 122
164		-	children. Such programs shall include, but need not be limited to, the 123
165		-	following: 124
166		-	(1) Same-day access, in all geographical areas, to family-centered 125
167		-	medication-assisted treatment that includes prenatal and perinatal care 126
168		-	and access to supports that provide a bridge to such treatment; 127
169		-	(2) Intensive in-home treatment supports; 128
170		-	(3) Gender-specific programming; 129
171		-	(4) Expanded access to residential programs for pregnant and 130
172		-	parenting persons, including residential programs for parents who have 131
173		-	more than one child or who have children over the age of seven; and 132
174		-	(5) Access to recovery support specialists and peer support to provide 133
175		-	care coordination. 134
176		-	(b) Not later than January 1, 2024, the Commissioners of Mental 135
177		-	Health and Addiction Services, Social Services and Children and 136
178		-	Families shall jointly report, in accordance with the provisions of section 137
179		-	11-4a of the general statutes, to the joint standing committees of the 138
180		-	General Assembly having cognizance of matters relating to public 139
181		-	health, human services and children regarding such plan and 140
182		-	recommendations for legislative changes necessary to implement the 141
183		-	programs described in subsection (a) of this section. 142
184		-	Sec. 6. (Effective from passage) The Departments of Mental Health and 143 Substitute Bill No. 6913
185		-
186		-
187		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
188		-	R01-HB.docx }
189		-	6 of 9
190		-
191		-	Addiction Services and Social Services shall, in collaboration with the 144
192		-	Office of Early Childhood, establish a plan to permit parents who are in 145
193		-	treatment for substance use disorder to be eligible for child care 146
194		-	supports and subsidies. Not later than January 1, 2024, the 147
195		-	Commissioners of Mental Health and Addiction Services and Social 148
196		-	Services shall jointly report, in accordance with the provisions of section 149
197		-	11-4a of the general statutes, to the joint standing committees of the 150
198		-	General Assembly having cognizance of matters relating to public 151
199		-	health and human services regarding such plan. 152
200		-	Sec. 7. (Effective from passage) The Departments of Mental Health and 153
201		-	Addiction Services, Social Services and Housing shall develop a plan to 154
202		-	ensure that pregnant and parenting persons with substance use disorder 155
203		-	who are in treatment for substance use disorder have access to 156
204		-	supportive housing. Not later than January 1, 2024, the Commissioners 157
205		-	of Mental Health and Addiction Services, Social Services and Housing 158
206		-	shall jointly report, in accordance with the provisions of section 11-4a of 159
207		-	the general statutes, to the joint standing committees of the General 160
208		-	Assembly having cognizance of matters relating to public health, 161
209		-	human services and housing regarding such plan. 162
210		-	Sec. 8. (Effective from passage) The Departments of Mental Health and 163
211		-	Addiction Services, Social Services and Children and Families shall 164
212		-	develop a plan to ensure that parents with substance use disorder whose 165
213		-	children are receiving services from the Department of Children and 166
214		-	Families have access to appropriate treatment for substance use 167
215		-	disorder both to prevent removal of children from their parents where 168
216		-	possible and to support reunification when removal is necessary, 169
217		-	including, but not limited to, consideration of in-home parenting and 170
218		-	child care services to assist with safety planning during initial stages of 171
219		-	treatment and recovery. Not later than January 1, 2024, the 172
220		-	Commissioners of Mental Health and Addiction Services, Social 173
221		-	Services and Children and Families shall jointly report, in accordance 174
222		-	with the provisions of section 11-4a of the general statutes, to the joint 175
223		-	standing committees of the General Assembly having cognizance of 176 Substitute Bill No. 6913
224		-
225		-
226		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
227		-	R01-HB.docx }
228		-	7 of 9
229		-
230		-	matters relating to public health, human services and children regarding 177
231		-	such plan. 178
232		-	Sec. 9. (Effective from passage) The Departments of Mental Health and 179
233		-	Addiction Services, Children and Families and Social Services shall 180
234		-	evaluate existing substance use disorder treatment services for pregnant 181
235		-	and parenting persons, utilization of such services and areas where 182
236		-	additional substance use disorder treatment services for such persons 183
237		-	are necessary. The Commissioners of Mental Health and Addiction 184
238		-	Services, Children and Families and Social Services shall jointly report, 185
239		-	not later than January 1, 2024, and semiannually thereafter until January 186
240		-	1, 2025, in accordance with the provisions of section 11-4a of the general 187
241		-	statutes, to the joint standing committees of the General Assembly 188
242		-	having cognizance of matters relating to public health regarding such 189
243		-	evaluation. 190
244		-	Sec. 10. (Effective from passage) The Department of Children and 191
245		-	Families shall evaluate the quality of practice, safety planning and 192
246		-	service delivery to families who are receiving services from the 193
247		-	department, including, but not limited to, the timely availability and 194
248		-	utilization of services necessary to mitigate child safety concerns in the 195
249		-	home when the child's caregiver has a substance use disorder and 196
250		-	tracking of outcomes for treatment for persons with a substance use 197
251		-	disorder who are caregivers of a child. Not later than January 1, 2024, 198
252		-	the Commissioner of Children and Families shall report, in accordance 199
253		-	with the provisions of section 11-4a of the general statutes, to the joint 200
254		-	standing committees of the General Assembly having cognizance of 201
255		-	matters relating to public health and children regarding such plan. 202
256		-	Sec. 11. Subsection (b) of section 17a-674d of the general statutes is 203
257		-	repealed and the following is substituted in lieu thereof (Effective July 1, 204
258		-	2023): 205
259		-	(b) The committee shall consist of the following members: 206
260		-	(1) The Secretary of the Office of Policy and Management, or the 207 Substitute Bill No. 6913
261		-
262		-
263		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
264		-	R01-HB.docx }
265		-	8 of 9
266		-
267		-	secretary's designee; 208
268		-	(2) The Attorney General, or the Attorney General's designee; 209
269		-	(3) The Commissioners of Children and Families, Mental Health and 210
270		-	Addiction Services and Public Health, or said commissioners' designees, 211
271		-	who shall serve as ex-officio members; 212
272		-	(4) The president pro tempore of the Senate, the speaker of the House 213
273		-	of Representatives, the majority leaders of the Senate and House of 214
274		-	Representatives, the minority leaders of the Senate and House of 215
275		-	Representatives, the Senate and House chairpersons of the joint 216
276		-	standing committee of the General Assembly having cognizance of 217
277		-	matters relating to appropriations and the budgets of state agencies, or 218
278		-	their designees, provided such persons have experience living with a 219
279		-	substance or disorder or are the family member of a person who has 220
280		-	experience living with a substance use disorder; 221
281		-	(5) Seventeen individuals representing municipalities, who shall be 222
282		-	appointed by the Governor; 223
283		-	(6) The executive director of the Commission on Racial Equity in 224
284		-	Public Health, or a representative of the commission designated by the 225
285		-	executive director; and 226
286		-	(7) [Six] Eight individuals appointed by the commissioner as follows: 227
287		-	(A) A provider of community-based substance use treatment services 228
288		-	for adults, who shall be a nonvoting member; (B) a provider of 229
289		-	community-based substance use treatment services for adolescents, 230
290		-	who shall be a nonvoting member; (C) an addiction medicine licensed 231
291		-	health care professional with prescribing ability, who shall be a 232
292		-	nonvoting member; [and] (D) three individuals with experience living 233
293		-	with a substance use disorder or family members of an individual with 234
294		-	experience living with a substance use disorder; and (E) two individuals 235
295		-	with experience supporting infants and children affected by the opioid 236
296		-	crisis. 237 Substitute Bill No. 6913
297		-
298		-
299		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2023HB-06913-
300		-	R01-HB.docx }
301		-	9 of 9
	154	+	LCO No. 6013 5 of 5
302	155
303	156		This act shall take effect as follows and shall amend the following
304	157		sections:
305	158
306	159		Section 1 from passage New section
307	160		Sec. 2 from passage 10a-55t
308	161		Sec. 3 from passage New section
309	162		Sec. 4 October 1, 2023 21a-317
310		-	Sec. 5 from passage New section
311		-	Sec. 6 from passage New section
312		-	Sec. 7 from passage New section
313		-	Sec. 8 from passage New section
314		-	Sec. 9 from passage New section
315		-	Sec. 10 from passage New section
316		-	Sec. 11 July 1, 2023 17a-674d(b)
317	163
318		-	Statement of Legislative Commissioners:
319		-	Section 1(1) was rewritten for clarity and in Section 10, "whose cases
320		-	are open with" was changed to "who are receiving services from" and
321		-	"when the child's caregiver has a substance use disorder" was inserted
322		-	after "home" for clarity.
323		-
324		-	PH Joint Favorable Subst.
	164	+	Statement of Purpose:
	165	+	To combat the opioid pandemic.
	166	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except
	167	+	that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not
	168	+	underlined.]
325	169